Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated...

Area of Science:

• Cardiovascular Surgery
• Biomaterials Science
• Immunology

Background:

• Coronary artery bypass grafting (CABG) involves cardiopulmonary bypass, which can trigger inflammatory responses.
• Heparin-coated circuits aim to improve biocompatibility during cardiopulmonary bypass.
• Understanding the impact on complement activation and inflammatory markers is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the effect of heparin-coated circuits versus uncoated circuits on complement activation.
• To assess the influence on neutrophil-mediated inflammatory response during CABG.
• To determine the impact on postoperative clinical recovery in patients undergoing CABG.

Main Methods:

• A randomized controlled trial involving 30 patients undergoing elective CABG.
• Comparison between 15 patients using heparin-coated circuits and 15 using uncoated circuits.
• Measurement of terminal complement complex and polymorphonuclear neutrophil elastase concentrations; analysis of a composite recovery score.

Main Results:

• Peak terminal complement complex concentrations were 38% lower in the heparin-coated circuit group (p = 0.004).
• A positive correlation was found between terminal complement complex and polymorphonuclear neutrophil elastase (rs = 0.74, p < 0.0007).
• The postoperative recovery score was significantly lower in the heparin-coated circuit group (p = 0.03).

Conclusions:

• Heparin-coated circuits, combined with full systemic heparinization, enhance biocompatibility by reducing complement activation during CABG.
• The use of heparin-coated circuits is associated with improved postoperative patient recovery.
• These findings suggest a clinical benefit of heparin-coated circuits in reducing inflammatory responses in cardiac surgery.